These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 18174700)

  • 21. Noonan syndrome and systemic lupus erythematosus in a patient with a novel KRAS mutation.
    Leventopoulos G; Denayer E; Makrythanasis P; Papapolychroniou C; Fryssira H
    Clin Exp Rheumatol; 2010; 28(4):556-7. PubMed ID: 20810036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome.
    Koh AL; Tan ES; Brett MS; Lai AHM; Jamuar SS; Ng I; Tan EC
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00581. PubMed ID: 30784236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
    Brasil AS; Malaquias AC; Wanderley LT; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
    Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):717-22. PubMed ID: 21340158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
    Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
    Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment.
    Padidela R; Camacho-Hübner C; Attie KM; Savage MO
    Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noonan syndrome associated with both a new Jnk-activating familial SOS1 and a de novo RAF1 mutations.
    Longoni M; Moncini S; Cisternino M; Morella IM; Ferraiuolo S; Russo S; Mannarino S; Brazzelli V; Coi P; Zippel R; Venturin M; Riva P
    Am J Med Genet A; 2010 Sep; 152A(9):2176-84. PubMed ID: 20683980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive genetic analysis of overlapping syndromes of RAS/RAF/MEK/ERK pathway.
    Tumurkhuu M; Saitoh M; Sato A; Takahashi K; Mimaki M; Takita J; Takeshita K; Hama T; Oka A; Mizuguchi M
    Pediatr Int; 2010 Aug; 52(4):557-62. PubMed ID: 20030748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral giant coronary aneurysms in a 40-year-old male with Noonan syndrome caused by a KRAS germline mutation.
    Fujimoto N; Nakajima H; Sugiura E; Dohi K; Kanemitsu S; Yamada N; Aoki Y; Nakatani K; Shimpo H; Nobori T; Ito M
    Int J Cardiol; 2014 May; 173(3):e63-6. PubMed ID: 24703799
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute lymphoblastic leukemia in the context of RASopathies.
    Cavé H; Caye A; Strullu M; Aladjidi N; Vignal C; Ferster A; Méchinaud F; Domenech C; Pierri F; Contet A; Cacheux V; Irving J; Kratz C; Clavel J; Verloes A
    Eur J Med Genet; 2016 Mar; 59(3):173-8. PubMed ID: 26855057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
    Tartaglia M; Pennacchio LA; Zhao C; Yadav KK; Fodale V; Sarkozy A; Pandit B; Oishi K; Martinelli S; Schackwitz W; Ustaszewska A; Martin J; Bristow J; Carta C; Lepri F; Neri C; Vasta I; Gibson K; Curry CJ; Siguero JP; Digilio MC; Zampino G; Dallapiccola B; Bar-Sagi D; Gelb BD
    Nat Genet; 2007 Jan; 39(1):75-9. PubMed ID: 17143282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
    Bertelloni S; Baroncelli GI; Dati E; Ghione S; Baldinotti F; Toschi B; Simi P
    Hormones (Athens); 2013; 12(1):86-92. PubMed ID: 23624134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noonan syndrome and related disorders: a review of clinical features and mutations in genes of the RAS/MAPK pathway.
    Jorge AA; Malaquias AC; Arnhold IJ; Mendonca BB
    Horm Res; 2009; 71(4):185-93. PubMed ID: 19258709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
    Dereure O
    Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
    [No Abstract]   [Full Text] [Related]  

  • 35. GH therapy in Noonan syndrome: Review of final height data.
    Dahlgren J
    Horm Res; 2009 Dec; 72 Suppl 2():46-8. PubMed ID: 20029237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
    Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costello syndrome and related disorders.
    Quezada E; Gripp KW
    Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in RAS-MAPK genes in 200 Spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy.
    Ezquieta B; Santomé JL; Carcavilla A; Guillén-Navarro E; Pérez-Aytés A; Sánchez del Pozo J; García-Miñaur S; Castillo E; Alonso M; Vendrell T; Santana A; Maroto E; Galbis L
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):447-55. PubMed ID: 22465605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair.
    Ferrero GB; Picco G; Baldassarre G; Flex E; Isella C; Cantarella D; Corà D; Chiesa N; Crescenzio N; Timeus F; Merla G; Mazzanti L; Zampino G; Rossi C; Silengo M; Tartaglia M; Medico E
    Hum Mutat; 2012 Apr; 33(4):703-9. PubMed ID: 22253195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
    Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
    Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.